Market Exclusive

Analyst Activity – HC Wainwright Reiterates Buy on Insmed (NASDAQ:INSM)

Analyst Ratings For Insmed (NASDAQ:INSM)

Today, HC Wainwright reiterated its Buy rating on Insmed (NASDAQ:INSM).

There are 1 hold rating, 4 buy ratings on the stock.

The current consensus rating on Insmed (NASDAQ:INSM) is Buy (Score: 2.80) with a consensus target price of $22.75 per share, a potential 44.35% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Insmed (NASDAQ:INSM)
Insmed (NASDAQ:INSM) has insider ownership of 5.10% and institutional ownership of 91.91%.

Recent Trading Activity for Insmed (NASDAQ:INSM)
Shares of Insmed closed the previous trading session at 15.76 down -0.41 -2.54% with 359,681 shares trading hands.

Exit mobile version